DE60205239D1 - Azol- oder triazol-derivate, verfahren zu deren herstellung und ihre verwendung als antifungale arzneimittel - Google Patents

Azol- oder triazol-derivate, verfahren zu deren herstellung und ihre verwendung als antifungale arzneimittel

Info

Publication number
DE60205239D1
DE60205239D1 DE60205239T DE60205239T DE60205239D1 DE 60205239 D1 DE60205239 D1 DE 60205239D1 DE 60205239 T DE60205239 T DE 60205239T DE 60205239 T DE60205239 T DE 60205239T DE 60205239 D1 DE60205239 D1 DE 60205239D1
Authority
DE
Germany
Prior art keywords
sup
azol
production
triazol derivatives
antifungal medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60205239T
Other languages
English (en)
Other versions
DE60205239T2 (de
Inventor
Didier Babin
John Weston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE60205239D1 publication Critical patent/DE60205239D1/de
Application granted granted Critical
Publication of DE60205239T2 publication Critical patent/DE60205239T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60205239T 2001-05-04 2002-05-02 Azol- oder triazol-derivate, verfahren zu deren herstellung und ihre verwendung als antifungale arzneimittel Expired - Lifetime DE60205239T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0105959A FR2824324B1 (fr) 2001-05-04 2001-05-04 Nouveaux derives d'azole ou de triazole, leur procede de preparation et leur application comme medicaments anti-fongiques
FR0105959 2001-05-04
PCT/FR2002/001519 WO2002090350A1 (fr) 2001-05-04 2002-05-02 Nouveaux derives d'azole ou de triazole, leur procede de preparation et leur application comme medicaments anti-fongiques

Publications (2)

Publication Number Publication Date
DE60205239D1 true DE60205239D1 (de) 2005-09-01
DE60205239T2 DE60205239T2 (de) 2006-05-24

Family

ID=8862967

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60205239T Expired - Lifetime DE60205239T2 (de) 2001-05-04 2002-05-02 Azol- oder triazol-derivate, verfahren zu deren herstellung und ihre verwendung als antifungale arzneimittel

Country Status (10)

Country Link
US (1) US6960600B2 (de)
EP (1) EP1387837B1 (de)
JP (1) JP4587641B2 (de)
AT (1) ATE300530T1 (de)
DE (1) DE60205239T2 (de)
DK (1) DK1387837T3 (de)
ES (1) ES2243725T3 (de)
FR (1) FR2824324B1 (de)
PT (1) PT1387837E (de)
WO (1) WO2002090350A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4488350B2 (ja) 2002-05-16 2010-06-23 セプラコール インク. 哺乳類アナンダミド輸送体を阻害するアミン、およびその使用方法
KR100572996B1 (ko) * 2003-08-12 2006-04-25 한국화학연구원 불소화 비닐 에테르 측쇄기를 갖는 아졸계 살균제 화합물및 그의 제조방법
US8188085B2 (en) * 2008-08-12 2012-05-29 Merck Sharp & Dohme Corp. Antifungal agents
WO2012172562A2 (en) * 2011-06-15 2012-12-20 Fdc Limited Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation
WO2015155738A2 (en) 2014-04-09 2015-10-15 Christopher Rudd Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3039087A1 (de) * 1980-10-16 1982-05-19 Hoechst Ag, 6000 Frankfurt 1-(1,3-dioxolan-2-ylmethyl)-azole, ihre salze, verfahren zu ihrer herstellung und ihre verwendung
DE3308554A1 (de) * 1983-03-10 1984-09-13 Hoechst Ag, 6230 Frankfurt 1-/1,3-dioxolan-2-ylmethyl)-azole, ihre salze, verfahren zu ihrer herstellung und ihre verwendung
US6140340A (en) * 1998-10-06 2000-10-31 Hoechst Marion Roussel Derivatives of 2-[3-phenyl-2-propenyl]-1,2,3,4-tetrahydro isoquinoline, their process and their use as fungicides
FR2807434B1 (fr) 2000-04-05 2002-10-18 Hoechst Marion Roussel Inc Nouveaux derives de la 1,2,3,4-tetrahydroisoquinoleine, leur procede de preparation et leur application comme fongicides

Also Published As

Publication number Publication date
JP2004532242A (ja) 2004-10-21
ES2243725T3 (es) 2005-12-01
WO2002090350A1 (fr) 2002-11-14
US20040192922A1 (en) 2004-09-30
ATE300530T1 (de) 2005-08-15
FR2824324A1 (fr) 2002-11-08
FR2824324B1 (fr) 2003-08-15
EP1387837A1 (de) 2004-02-11
DK1387837T3 (da) 2005-11-14
EP1387837B1 (de) 2005-07-27
DE60205239T2 (de) 2006-05-24
US6960600B2 (en) 2005-11-01
JP4587641B2 (ja) 2010-11-24
PT1387837E (pt) 2005-10-31

Similar Documents

Publication Publication Date Title
RS50209B (sr) Derivati pirazolokarboksilne kiseline, njihova priprema, farmaceutske kompozicije sa sadržajem istih
CA2390649A1 (en) 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
AU7278500A (en) Fungicides
TW200604179A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
BR0007500A (pt) Composto triazol, fármaco, e, uso do composto
CA2269721A1 (en) 1-phenylpyrazole compounds and medicinal application thereof
ATE316083T1 (de) Adamantanderivate
ATE353216T1 (de) 1-substituierten imidazol derivaten als nos inhibitoren
DE602004011966D1 (en) Heterocyclylverbindungen
WO2002094020A8 (de) Verwendung von triazolopyrimidin-derivaten als mikrobizide im materialschutz
ES8707190A1 (es) Procedimiento para la obtencion de -aril-1h-azol-1-etanoles
DE50011179D1 (de) Aminocarbonyl-substituierte benzimidazolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE60205239D1 (de) Azol- oder triazol-derivate, verfahren zu deren herstellung und ihre verwendung als antifungale arzneimittel
ATE282615T1 (de) Neue beta-amyloid inhibitoren, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE60209708D1 (de) Azol- oder triazol-derivate, verfahren zu deren herstellung und ihre verwendung als fungizide
ATE264847T1 (de) Verzweigte substituierte aminoderivate vom 3- amino-1-phenyl-1h(1,2,4)triazol, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
EP1270572A4 (de) Kondensierte pyrazol-derivate, verfahren zu ihrer herstellung und ihre verwndung
WO2001010861A3 (de) Substituierte heterocyclyl-2h-chromene
DE58906765D1 (de) Substituierte Bisazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
MXPA03010914A (es) DERIVADOS DE HALOFENILO INTERMEDIARIOS Y SU USO EN UN PROCESO PARA LA PREPARACIoN DE DERIVADOS DE AZOL.
DE3783946D1 (de) Triazol- oder imidazol- und tetrahydrofuran-verbindungen, ihre verwendung als fungizide und verfahren zu deren herstellung.
WO2000011951A3 (de) Verwendung von 5-amino-pyrazol-derivaten zur bekämpfung von mikrooranismen
DE69943259D1 (de) Neue 2-Halogen-Derivate von 5-O-Desosaminylerythronolid A, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
WO2001079196A3 (en) 1-(h-1,2,4-triazol-1-yl)butan-2-ol derivatives
EP1043306A3 (de) 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC